Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People
Peter A Maple1,2, Radu Tanasescu1,2, Cris S Constantinescu1,3
1Mental Health and Clinical Neuroscience Academic Unit, University of Nottingham School of Medicine, Nottingham NG7 2UH, UK.
Abstract:
Previous exposure to Epstein-Barr virus (EBV) is strongly associated with the development of multiple sclerosis (MS). By contrast, past cytomegalovirus (CMV) infection may have no association, or be negatively associated with MS. This study aimed to investigate the associations of herpesvirus infections with MS in an Italian population. Serum samples (n = 200) from Italian people with multiple sclerosis (PwMS) classified as the relapsing-and-remitting clinical phenotype and (n = 137) healthy controls (HCs) were obtained from the CRESM Biobank, Orbassano, Italy. Both PwMS and HCs samples were selected according to age group (20-39 years, and 40 or more years) and sex. EBV virus capsid antigen (VCA) IgG, EBV nucleic acid-1 antigen (EBNA-1) IgG, CMV IgG, herpes simplex virus (HSV) IgG, and varicella zoster virus (VZV) IgG testing was undertaken using commercial ELISAs. EBV VCA IgG and EBNA-1 IgG seroprevalences were 100% in PwMS and 93.4% and 92.4%, respectively, in HCs. EBV VCA IgG and EBNA-1 IgG levels were higher (p < 0.001) in PwMS compared with HCs. For PwMS, the EBNA-1 IgG levels decreased with age, particularly in females. The CMV IgG seroprevalence was 58.7% in PwMS and 62.9% in HCs. CMV IgG seroprevalence increased with age. The HSV IgG seroprevalence was 71.2% in PwMS and 70.8% in HCs. HSV IgG levels were lower (p = 0.0005) in PwMS compared with HCs. VZV IgG seroprevalence was 97.5% in PwMS and 98.5% in HCs. In the population studied, several herpesvirus infections markers may have been influenced by the age and sex of the groups studied. The lack of a negative association of MS with CMV infection, and the observation of lower levels of HSV IgG in PwMS compared with HCs are findings worthy of further investigation.
Insights
Epstein-Barr virus (EBV) infection is linked to multiple sclerosis (MS), with higher EBV antibody levels found in people with MS. Cytomegalovirus (CMV) showed no negative association, and herpes simplex virus (HSV) antibodies were lower in MS patients.
Area of Science:
- Virology and Immunology
- Neuroscience
- Epidemiology
Background:
- Epstein-Barr virus (EBV) exposure is a known risk factor for multiple sclerosis (MS).
- The association of cytomegalovirus (CMV) with MS is less clear, potentially being neutral or negative.
- Understanding the role of various herpesviruses in MS pathogenesis is crucial.
Purpose of the Study:
- To investigate the association between different herpesvirus infections and MS in an Italian population.
- To compare seroprevalence and antibody levels of EBV, CMV, HSV, and VZV in people with MS (PwMS) and healthy controls (HCs).
- To explore the influence of age and sex on these associations.
Main Methods:
- Serum samples from 200 Italian PwMS (relapsing-remitting phenotype) and 137 HCs were analyzed.
- Samples were matched for age and sex.
- Commercial ELISAs were used to detect IgG antibodies against EBV (VCA and EBNA-1), CMV, HSV, and VZV.
Main Results:
- EBV VCA IgG and EBNA-1 IgG seroprevalence was high (100% in PwMS, ~93% in HCs), with significantly higher levels in PwMS (p < 0.001).
- EBNA-1 IgG levels decreased with age in female PwMS.
- CMV IgG seroprevalence was similar in PwMS (58.7%) and HCs (62.9%) and increased with age. HSV IgG levels were lower in PwMS (71.2%) compared to HCs (70.8%) (p = 0.0005). VZV IgG seroprevalence was high in both groups (~98%).
Conclusions:
- The study confirms a strong association between EBV infection markers and MS in the Italian population studied.
- The lack of a negative association with CMV and lower HSV IgG levels in PwMS warrant further investigation.
- Age and sex can influence herpesvirus infection markers in relation to MS.
Related Concept Videos
Arboviral Encephalitis
Cytomegalovirus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Viral Hepatitis I: Introduction


